Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide versus dulaglutide once-weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Mechanisms linking obesity with cardiovascular disease
Mechanistic sampling of intestinal tissue during this trial would best validate the reparative hypothesis if analyses include tight junction protein expression (e.g., claudins, occludin, zonula occludens-1), histologic healing assessments using validated indices (e.g., Geboes score, Robarts Histopathology Index), and intestinal permeability assays such as the lactulose-mannitol ratio
The FDA labeling for most GLP-1 receptor agonists simply says "any time of day." But that does not mean timing is irrelevant
Chen DL, Xiang JN, Yang LY
A review of its use in type 2 diabetes mellitus
US$ 23.67
US$ 29.64
US$ 22.59
US$ 25.22
US$ 29.71
US$ 25.34
